Literature DB >> 12164282

Coleonema album: studies of the pharmacological action on smooth muscle in vitro and antimicrobial action of its essential oil.

Maria Lis-Balchin1, Stephen L Hart.   

Abstract

The mode of action of the essential oil of Coleonema album, a South African species from the Cape region, was studied on smooth muscle in vitro using field-stimulated guinea-pig ileum. The oil produced an initial spasmogenic activity followed by spasmolysis, both actions being dose-dependent. The spasmolytic action was post-synaptic and not atropine-like and was unaffected by the adrenoceptor blockers phentolamine and propranolol. There was no evidence for the involvement of either cyclic guanosine monophosphate or cyclic adenosine monophosphate in the spasmolytic activity. The oil had some calcium channel blocking activity but this is not the primary explanation for its spasmolytic response. Antimicrobial activity against Pseudomonas aeruginosa, Escherichia coli, Staphyloccocus aureus and Saccharomyces cerevisiae was very low and totally absent against Enterococcus hirae, suggesting that the oil has no worthwhile potential in this area. However, as the oil has a very disagreeable odour in its undiluted form, it could be a powerful insect repellent, as its local usage suggests, and this remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164282     DOI: 10.1002/ptr.863

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  2 in total

1.  Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipation.

Authors:  Francesca Borrelli; Francesco Capasso; Raffaele Capasso; Valeria Ascione; Gabriella Aviello; Rocco Longo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

2.  Antifungal and antioxidant activities of Coleonema album and C. pulchellum against skin diseases.

Authors:  Olufunke O Fajinmi; Jiří Grúz; Petr Tarkowski; Manoj G Kulkarni; Jeffrey F Finnie; Johannes Van Staden
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.